Clinical Trials
35 trialsNotable-HCC
Shandong Cancer Hospital and Institute
Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC
Sun Yat-sen University
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
First Affiliated Hospital of Guangxi Medical University
BRPCNCC-1
Changhai Hospital
SBRT Plus vNKT for Pancreatic Cancer
Changhai Hospital
Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer
Changhai Hospital
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
First Affiliated Hospital of Zhejiang University
COLLISION-XL
Amsterdam UMC, location VUmc
FIBROPANC-1
Erasmus Medical Center
Tislelizumab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With Advanced CRC
Huazhong University of Science and Technology
Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors
Instituto de investigación e innovación biomédica de Cádiz
MASTERPLAN
Australasian Gastro-Intestinal Trials Group
TASABR
Dalin Tzu Chi General Hospital
SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma
The University of Hong Kong
ISBRT01
Sun Yat-sen University
RFA vs. SBRT for Small HCC
Sun Yat-sen University
SAIL
Sun Yat-sen University
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
Guangxi Medical University
Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT
Sun Yat-sen University
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm
Korea Cancer Center Hospital
Ckvsmalm
Peking University Third Hospital
Ckvssip
Peking University Third Hospital
Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis
ChineseAMS
Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
IRENE
IRCCS Azienda Ospedaliero-Universitaria di Bologna
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Hangzhou Cancer Hospital
STH
Gangneung Asan Hospital
A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely
AHS Cancer Control Alberta
IFCSLAPC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife
Tianjin Medical University Cancer Institute and Hospital
Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer
ChineseAMS
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
The Cooper Health System
Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
AHS Cancer Control Alberta